The Histiocytosis Association’s Request for Research Proposals funds studies advancing understanding, diagnosis, and treatment of histiocytic disorders, especially rare subtypes and patient-centered outcomes.
Funder: Histiocytosis Association
Due Dates (Anticipated): April 2027 (application window opens) | June 2027 (full application deadline)
Funding Amounts: Up to $50,000 per one-year project; no overhead, PI salary, or travel allowed.
Summary: Supports research to advance understanding, diagnosis, and treatment of histiocytic disorders, with emphasis on disease mechanisms, rare subtypes, and patient-centered outcomes.
The Histiocytosis Association invites scientific research proposals focused on the causes, mechanisms, and improved treatments for histiocytic disorders. This annual funding opportunity encourages studies on disease pathogenesis, immune cell biology, cytokine function, rare subtypes (such as juvenile xanthogranuloma, Erdheim-Chester disease, and Rosai-Dorfman disease), adult presentations, biomarker discovery, and quality of life or survivorship. Proposals are evaluated for scientific merit, feasibility, and relevance—especially patient-centeredness—with the aim of advancing knowledge and care in the field of histiocytosis.